Dubai, United Arab Emirates, 2nd Dec 2024 – Global blockchain company GenomeFi garnered significant attention at KoINDEX 2024, held from November 21 to 23 at the YashoBhoomi Exhibition Center in New Delhi, India, by showcasing its AI-powered Web3 genomic Decentralized Identity (DID) platform.
KoINDEX 2024, an international industrial exhibition, commemorated the 50th anniversary of Korea-India diplomatic relations, aiming to strengthen economic cooperation between the two nations and support the global expansion of South Korean SMEs. The event concluded successfully, featuring over 280 companies, 600 booths, and more than 14,000 visitors.
At the exhibition, GenomeFi demonstrated its innovative platform for securely protecting and utilizing healthcare data, strengthening its presence in the global market, and exploring collaborative opportunities within the Indian market.
GenomeFi unveiled its genome-based DID platform, which integrates AI and blockchain to present new possibilities for healthcare data utilization. Its technology, designed to enhance data security and ownership protection while fostering an incentive-based ecosystem, attracted significant interest from local healthcare professionals.
A medical professional remarked, “GenomeFi’s technology addresses critical data security challenges and opens up possibilities for personalized medical services,” highlighting its immense value.
During the exhibition, GenomeFi’s booth attracted over 1,500 visitors. Attendees experienced its AI-driven genomic analysis services firsthand and learned how personalized medical solutions have the potential to transform the healthcare industry.
In addition to its booth activities, GenomeFi participated in the Technology and Healthcare Innovation Seminar at KoINDEX 2024, presenting on the transformative impact of AI and blockchain integration on the healthcare industry. The company also engaged in collaboration discussions with 15 local medical institutions and biotech companies, solidifying pilot projects with five of them.
Through KoINDEX 2024, GenomeFi demonstrated its technological leadership in the global market and validated its potential for expansion into India and other Asian markets. Interactions with major healthcare and tech companies paved the way for developing localized healthcare solutions tailored to the region’s needs.
GenomeFi plans to launch its first collaborative project in the Indian market by the first half of 2025. This project aims to analyze genomic data from over 30,000 individuals and deliver personalized medical services, setting new benchmarks for healthcare data utilization.
KoINDEX 2024 showcased how the fusion of AI and blockchain can revolutionize the future of the healthcare industry. GenomeFi has proven its readiness to pioneer a new paradigm in healthcare by protecting data ownership and enabling personalized medical services. The company is committed to expanding innovative healthcare solutions in global markets through ongoing collaborations, solidifying its position as a leader in healthcare data innovation.
Media Contact
Organization: Genomefi
Contact Person: Soonzero
Website: https://genomefi.io/
Email: Send Email
City: Dubai
Country: United Arab Emirates
Release Id: 02122420742
The post GenomeFi Gains Recognition for Innovative Healthcare Technology at KoINDEX 2024 appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.